Thermo Fisher Scientific Gross Margin 2010-2022 | TMO

Current and historical gross margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current gross profit margin for Thermo Fisher Scientific as of December 31, 2022 is %.
Thermo Fisher Scientific Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-12-31 $44.92B $19.10B 42.52%
2022-09-30 $44.17B $19.62B 44.42%
2022-06-30 $42.82B $19.97B 46.63%
2022-03-31 $41.12B $19.89B 48.37%
2021-12-31 $39.21B $19.64B 50.08%
2021-09-30 $39.06B $19.94B 51.05%
2021-06-30 $38.25B $19.62B 51.29%
2021-03-31 $35.89B $18.47B 51.47%
2020-12-31 $32.22B $16.00B 49.67%
2020-09-30 $28.50B $13.48B 47.31%
2020-06-30 $26.25B $11.92B 45.39%
2020-03-31 $25.65B $11.36B 44.30%
2019-12-31 $25.54B $11.33B 44.35%
2019-09-30 $25.22B $11.22B 44.48%
2019-06-30 $24.87B $11.07B 44.51%
2019-03-31 $24.63B $10.98B 44.60%
2018-12-31 $24.36B $10.86B 44.57%
2018-09-30 $23.90B $10.60B 44.37%
2018-06-30 $23.09B $10.29B 44.55%
2018-03-31 $22.01B $9.84B 44.69%
2017-12-31 $20.92B $9.45B 45.17%
2017-09-30 $19.82B $9.06B 45.70%
2017-06-30 $19.20B $8.81B 45.90%
2017-03-31 $18.74B $8.61B 45.92%
2016-12-31 $18.27B $8.37B 45.82%
2016-09-30 $17.97B $8.20B 45.62%
2016-06-30 $17.61B $8.03B 45.60%
2016-03-31 $17.34B $7.89B 45.50%
2015-12-31 $16.97B $7.76B 45.72%
2015-09-30 $16.81B $7.74B 46.05%
2015-06-30 $16.85B $7.79B 46.23%
2015-03-31 $16.91B $7.70B 45.52%
2014-12-31 $16.89B $7.49B 44.36%
2014-09-30 $15.86B $6.88B 43.39%
2014-06-30 $14.89B $6.30B 42.30%
2014-03-31 $13.80B $5.81B 42.11%
2013-12-31 $13.09B $5.53B 42.24%
2013-09-30 $12.88B $5.43B 42.17%
2013-06-30 $12.78B $5.38B 42.13%
2013-03-31 $12.65B $5.34B 42.24%
2012-12-31 $12.51B $5.30B 42.33%
2012-09-30 $12.30B $5.20B 42.29%
2012-06-30 $12.15B $5.12B 42.18%
2012-03-31 $11.90B $4.96B 41.73%
2011-12-31 $11.56B $4.79B 41.47%
2011-09-30 $11.05B $4.59B 41.49%
2011-06-30 $10.75B $4.43B 41.21%
2011-03-31 $10.49B $4.32B 41.15%
2010-12-31 $10.39B $4.26B 41.00%
2010-09-30 $10.49B $4.19B 39.91%
2010-06-30 $10.40B $4.14B 39.80%
2010-03-31 $10.28B $4.08B 39.64%
2009-12-31 $9.91B $3.90B 39.32%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $230.517B $44.915B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00